PEOPLE - World Heart (US) makes appointment:
This article was originally published in Clinica
Executive Summary
World Heart, the Canadian developer of an artificial heart and related technologies, has named Dr Gerard Guiraudon director of clinical trials for its HEARTSAVERvad. The company has planned the first human implant of the device to take place later this year at the Ottawa Institute.